Topical vitamin A acid in the treatment of acne vulgaris (a controlled multicenter trial). 1976

M Gandola, and G Argenziano, and C Barba, and R Bassi, and M Binazzi, and G Landi, and L Levi, and D Randazzo, and F Serri, and A P Villano

A controlled non-blind multicenter trial was conducted in 211 acne patients to test the activity of topical retinoic acid against sulfur-resorcinol--salicylic acid and placebo. Uniform evaluation criteria were used. After 8 weeks' treatment in comparable groups of patients, retinoic acid proved to be superior to the standard and to the placebo. The difference was statistically significant. Side effects were present in a number of patients treated with the active substances and with the placebo (mainly erythema), but rarely was the treatment discontinued.

UI MeSH Term Description Entries
D008297 Male Males
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D012118 Resorcinols A water-soluble crystalline benzene-1,3-diol (resorcinol) and its derivatives. m-Dihydroxybenzenes,meta-Dihydroxybenzenes,m Dihydroxybenzenes,meta Dihydroxybenzenes
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000152 Acne Vulgaris A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors. Acne
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014212 Tretinoin An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE). Retinoic Acid,Vitamin A Acid,Retin-A,Tretinoin Potassium Salt,Tretinoin Sodium Salt,Tretinoin Zinc Salt,Vesanoid,all-trans-Retinoic Acid,beta-all-trans-Retinoic Acid,trans-Retinoic Acid,Acid, Retinoic,Acid, Vitamin A,Acid, all-trans-Retinoic,Acid, beta-all-trans-Retinoic,Acid, trans-Retinoic,Potassium Salt, Tretinoin,Retin A,Salt, Tretinoin Potassium,Salt, Tretinoin Sodium,Salt, Tretinoin Zinc,Sodium Salt, Tretinoin,Zinc Salt, Tretinoin,all trans Retinoic Acid,beta all trans Retinoic Acid,trans Retinoic Acid

Related Publications

M Gandola, and G Argenziano, and C Barba, and R Bassi, and M Binazzi, and G Landi, and L Levi, and D Randazzo, and F Serri, and A P Villano
December 1969, Pennsylvania medicine,
M Gandola, and G Argenziano, and C Barba, and R Bassi, and M Binazzi, and G Landi, and L Levi, and D Randazzo, and F Serri, and A P Villano
January 1974, Dermatologica,
M Gandola, and G Argenziano, and C Barba, and R Bassi, and M Binazzi, and G Landi, and L Levi, and D Randazzo, and F Serri, and A P Villano
September 1978, Singapore medical journal,
M Gandola, and G Argenziano, and C Barba, and R Bassi, and M Binazzi, and G Landi, and L Levi, and D Randazzo, and F Serri, and A P Villano
January 1974, Dermatologica,
M Gandola, and G Argenziano, and C Barba, and R Bassi, and M Binazzi, and G Landi, and L Levi, and D Randazzo, and F Serri, and A P Villano
April 1969, Archives of dermatology,
M Gandola, and G Argenziano, and C Barba, and R Bassi, and M Binazzi, and G Landi, and L Levi, and D Randazzo, and F Serri, and A P Villano
January 1975, Acta dermato-venereologica. Supplementum,
M Gandola, and G Argenziano, and C Barba, and R Bassi, and M Binazzi, and G Landi, and L Levi, and D Randazzo, and F Serri, and A P Villano
June 1974, Southern medical journal,
M Gandola, and G Argenziano, and C Barba, and R Bassi, and M Binazzi, and G Landi, and L Levi, and D Randazzo, and F Serri, and A P Villano
January 1976, Indian journal of dermatology, venereology and leprology,
M Gandola, and G Argenziano, and C Barba, and R Bassi, and M Binazzi, and G Landi, and L Levi, and D Randazzo, and F Serri, and A P Villano
March 1979, Lakartidningen,
M Gandola, and G Argenziano, and C Barba, and R Bassi, and M Binazzi, and G Landi, and L Levi, and D Randazzo, and F Serri, and A P Villano
November 1971, The British journal of dermatology,
Copied contents to your clipboard!